Y Liang Selected Research

adenylate cyclase 3

5/2017	Liraglutide reduces body weight by upregulation of adenylate cyclase 3.
1/2016	Hepatic adenylate cyclase 3 is upregulated by Liraglutide and subsequently plays a protective role in insulin resistance and obesity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Y Liang Research Topics

Disease

29	Neoplasms (Cancer) 08/2020 - 01/2000
13	Inflammation (Inflammations) 08/2022 - 08/2000
8	Breast Neoplasms (Breast Cancer) 07/2017 - 02/2001
7	Body Weight (Weight, Body) 02/2021 - 12/2001
7	Infections 10/2018 - 08/2000
6	Prostatic Neoplasms (Prostate Cancer) 12/2018 - 02/2000
5	Asthma (Bronchial Asthma) 11/2018 - 03/2001
5	Type 2 Diabetes Mellitus (MODY) 01/2018 - 12/2001
5	Neoplasm Metastasis (Metastasis) 10/2016 - 09/2002
5	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 10/2000
4	Hyperglycemia 06/2021 - 05/2001
4	Hypoxia (Hypoxemia) 01/2021 - 11/2014
4	Insulin Resistance 11/2020 - 07/2007
4	Pancreatic Neoplasms (Pancreatic Cancer) 07/2016 - 02/2008
4	Nasopharyngeal Carcinoma 07/2014 - 09/2010
4	Schizophrenia (Dementia Praecox) 07/2012 - 01/2005
4	Carcinoma (Carcinomatosis) 03/2004 - 02/2001
3	Burns 02/2021 - 08/2018
3	Poisoning 12/2020 - 02/2017
3	Necrosis 08/2019 - 07/2007
3	Acquired Immunodeficiency Syndrome (AIDS) 06/2019 - 06/2016
3	Carcinogenesis 03/2019 - 02/2012
3	Hepatocellular Carcinoma (Hepatoma) 06/2018 - 02/2001
3	Obesity 05/2017 - 01/2016
3	Lung Neoplasms (Lung Cancer) 01/2017 - 07/2014
3	Autoimmune Diseases (Autoimmune Disease) 01/2015 - 11/2000
3	Stomach Neoplasms (Stomach Cancer) 02/2012 - 08/2001
3	Prurigo 06/2001 - 08/2000
3	Polymyositis 11/2000 - 03/2000
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 06/2021
2	Glioma (Gliomas) 01/2022 - 06/2011
2	Coronary Artery Disease (Coronary Atherosclerosis) 09/2021 - 06/2010
2	Fibrosis (Cirrhosis) 01/2021 - 01/2020
2	Wounds and Injuries (Trauma) 06/2020 - 01/2020
2	Pain (Aches) 01/2020 - 10/2009
2	Scoliosis 01/2020 - 07/2018
2	Congenital Abnormalities (Deformity) 01/2020 - 03/2002
2	Hyperplasia 01/2020 - 11/2001
2	Cicatrix (Scar) 01/2020 - 01/2015
2	Hypertension (High Blood Pressure) 03/2019 - 12/2004
2	Rheumatoid Arthritis 01/2019 - 01/2015
2	Parkinson Disease (Parkinson's Disease) 03/2018 - 01/2018
2	Infarction (Infarctions) 01/2018 - 01/2015

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2001
9	Insulin (Novolin)FDA Link 01/2022 - 02/2000
8	Biomarkers (Surrogate Marker)IBA 08/2022 - 12/2004
8	Blood Glucose (Blood Sugar)IBA 06/2021 - 07/2005
8	Glucose (Dextrose)FDA LinkGeneric 05/2019 - 02/2000
8	Pharmaceutical PreparationsIBA 07/2016 - 01/2000
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2021 - 05/2000
5	Biological ProductsIBA 03/2019 - 10/2001
5	CytokinesIBA 08/2018 - 07/2007
5	MicroRNAs (MicroRNA)IBA 11/2017 - 10/2008
5	LigandsIBA 04/2016 - 10/2001
4	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2001
4	Messenger RNA (mRNA)IBA 07/2020 - 05/2000
4	CollagenIBA 01/2020 - 05/2001
4	Paclitaxel (Taxol)FDA LinkGeneric 11/2004 - 01/2000
3	EnzymesIBA 08/2022 - 10/2001
3	AntioxidantsIBA 01/2022 - 06/2011
3	InterleukinsIBA 06/2021 - 07/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2020 - 06/2011
3	Therapeutic UsesIBA 01/2020 - 06/2001
3	Hormones (Hormone)IBA 08/2019 - 02/2011
3	VaccinesIBA 09/2017 - 09/2001
3	AntibodiesIBA 11/2015 - 10/2001
3	Cisplatin (Platino)FDA LinkGeneric 07/2015 - 02/2008
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2013 - 03/2001
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2011 - 11/2004
3	AndrogensIBA 10/2001 - 02/2000
3	Mifepristone (RU 486)FDA Link 10/2001 - 02/2000
2	NF-kappa B (NF-kB)IBA 01/2022 - 01/2015
2	SodiumIBA 02/2021 - 12/2004
2	Indicators and Reagents (Reagents)IBA 02/2021 - 02/2013
2	Immunoglobulin G (IgG)IBA 02/2021 - 01/2021
2	Histones (Histone)IBA 01/2021 - 01/2020
2	mocetinostatIBA 01/2021 - 01/2020
2	beta CateninIBA 01/2021 - 02/2001
2	Oxygen (Dioxygen)IBA 01/2021 - 03/2000
2	Glutathione (Reduced Glutathione)IBA 07/2020 - 05/2010
2	AlbuminsIBA 07/2020 - 08/2001
2	Thymidine Monophosphate (TMP)IBA 06/2019 - 02/2017
2	Coloring Agents (Dyes)IBA 02/2019 - 01/2018
2	RotenoneIBA 03/2018 - 01/2017
2	SynucleinsIBA 01/2018 - 01/2017
2	Long Noncoding RNAIBA 01/2018 - 07/2014
2	HomocysteineIBA 01/2018 - 05/2014
2	Small Interfering RNA (siRNA)IBA 11/2017 - 10/2011
2	Estrogen ReceptorsIBA 07/2017 - 01/2017
2	adenylate cyclase 3IBA 05/2017 - 01/2016
2	Liraglutide FDA Link 05/2017 - 01/2016

Therapy/Procedure

18	Therapeutics 01/2021 - 03/2000
5	Drug Therapy (Chemotherapy) 07/2017 - 02/2012
3	Radiotherapy 01/2022 - 04/2012
3	Laminectomy 01/2021 - 01/2015
2	Length of Stay 01/2022 - 10/2015
2	Aftercare (After-Treatment) 12/2021 - 12/2001
2	Secondary Prevention 09/2021 - 06/2010
2	Minimally Invasive Surgical Procedures 01/2020 - 07/2018
2	Transplantation 01/2018 - 01/2015